Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)
77.08 x 1 77.15 x 2
Post-market by (Cboe BZX)
76.86 -1.93 (-2.45%) 03/21/25 [NYSE]
77.08 x 1 77.15 x 2
Post-market 76.91 +0.05 (+0.07%) 19:22 ET
Quote Overview for Fri, Mar 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
75.52
Day High
77.29
Open 75.96
Previous Close 78.79 78.79
Volume 5,880,400 5,880,400
Avg Vol 7,284,760 7,284,760
Stochastic %K 24.40% 24.40%
Weighted Alpha -45.94 -45.94
5-Day Change -0.29 (-0.38%) -0.29 (-0.38%)
52-Week Range 73.80 - 148.15 73.80 - 148.15
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 344,911,712
  • Shares Outstanding, K 4,487,532
  • Annual Sales, $ 42,108 M
  • Annual Income, $ 14,643 M
  • EBIT $ 18,609 M
  • EBITDA $ 21,380 M
  • 60-Month Beta 0.42
  • Price/Sales 8.39
  • Price/Cash Flow 20.30
  • Price/Book 16.99

Options Overview Details

View History
  • Implied Volatility 43.22% ( +0.20%)
  • Historical Volatility 48.37%
  • IV Percentile 82%
  • IV Rank 55.90%
  • IV High 58.88% on 12/19/24
  • IV Low 23.37% on 06/12/24
  • Put/Call Vol Ratio 1.14
  • Today's Volume 31,902
  • Volume Avg (30-Day) 30,568
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 460,465
  • Open Int (30-Day) 400,401

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.94
  • Number of Estimates 4
  • High Estimate 1.00
  • Low Estimate 0.84
  • Prior Year 0.83
  • Growth Rate Est. (year over year) +13.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.80 +4.15%
on 03/12/25
Period Open: 88.08
93.80 -18.06%
on 02/25/25
-11.22 (-12.74%)
since 02/21/25
3-Month
73.80 +4.15%
on 03/12/25
Period Open: 85.00
93.80 -18.06%
on 02/25/25
-8.14 (-9.58%)
since 12/20/24
52-Week
73.80 +4.15%
on 03/12/25
Period Open: 129.83
148.15 -48.12%
on 06/25/24
-52.97 (-40.80%)
since 03/21/24

Most Recent Stories

More News
This Vanguard ETF Is Crushing the Market in 2025. Should You Buy?

President Donald Trump has been in office for only two months, but already his saber-rattling over tariffs has roiled markets.

VEA : 52.05 (-0.55%)
SAP : 272.53 (+0.31%)
NVO : 76.86 (-2.45%)
$SPX : 5,667.56 (+0.08%)
TM : 190.70 (-0.76%)
HSBC : 57.83 (+0.38%)
NSRGY : 103.5500 (+0.04%)
ASML : 716.22 (-2.43%)
Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

It's hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug market is expected to generate $12.8 billion in sales this year, and according...

VKTX : 28.95 (+2.12%)
NVO : 76.86 (-2.45%)
LLY : 837.57 (-0.59%)
GSK Stock Recovers, Rises Around 17% YTD: Time to Buy, Sell or Hold?

GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below. The stock has...

NVO : 76.86 (-2.45%)
LLY : 837.57 (-0.59%)
HLN : 10.28 (-1.06%)
GSK : 39.24 (-0.43%)
Is This Simple Index Fund a Millionaire Maker?

Wondering if you should look beyond American markets to build your fortune? This widely held international fund offers a few opportunities and several challenges.

MSFT : 391.26 (+1.14%)
NVDA : 117.70 (-0.70%)
AAPL : 218.27 (+1.95%)
VEA : 52.05 (-0.55%)
SAP : 272.53 (+0.31%)
NVO : 76.86 (-2.45%)
$SPX : 5,667.56 (+0.08%)
VOO : 520.26 (+0.02%)
ASML : 716.22 (-2.43%)
Is Novo Nordisk a No-Brainer Buy After It Dropped 40%?

In this video, I will cover the recent updates regarding Novo Nordisk (NYSE: NVO) . Watch the short video to learn more, consider subscribing, and click the special offer link below.

VKTX : 28.95 (+2.12%)
NVO : 76.86 (-2.45%)
Why Novo Nordisk Stock Outpaced the Market on Tuesday

Novo Nordisk (NYSE: NVO), the Danish company best known as the maker of weight loss drug Wegovy, expanded a little on the stock exchange Tuesday. The company was one of the rare enterprises seeing an increase...

NVO : 76.86 (-2.45%)
$SPX : 5,667.56 (+0.08%)
UBS : 32.74 (-0.76%)
LLY : 837.57 (-0.59%)
Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?

Amgen’s AMGN stock has risen 21.7% so far this year compared with an increase of 7% for the industry.AMGN Stock PerformanceImage Source: Zacks Investment ResearchAmgen’s stock has been rising consistently,...

NVO : 76.86 (-2.45%)
LLY : 837.57 (-0.59%)
ABBV : 210.01 (-0.92%)
AMGN : 316.04 (+0.32%)
Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?

Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug.

VKTX : 28.95 (+2.12%)
NVO : 76.86 (-2.45%)
HIMS : 34.75 (+5.72%)
LLY : 837.57 (-0.59%)
Why Hims & Hers Stock Popped on Monday

Morgan Stanley had great news for Hims & Hers stock today, so why didn't it upgrade the stock?

AAPL : 218.27 (+1.95%)
HIMS : 34.75 (+5.72%)
NVO : 76.86 (-2.45%)
MS : 120.14 (-0.27%)
LLY : 837.57 (-0.59%)
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility .

NVO : 76.86 (-2.45%)
VRTX : 503.20 (-1.37%)
LLY : 837.57 (-0.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care...

See More

Key Turning Points

3rd Resistance Point 79.36
2nd Resistance Point 78.33
1st Resistance Point 77.59
Last Price 76.86
1st Support Level 75.82
2nd Support Level 74.79
3rd Support Level 74.05

See More

52-Week High 148.15
Fibonacci 61.8% 119.75
Fibonacci 50% 110.97
Fibonacci 38.2% 102.20
Last Price 76.86
52-Week Low 73.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals